FAIRCHEMOR
Fairchem Organics Limited
Specialty and commodity chemicals manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
fairchem.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Fairchem Organics makes specialty oleochemicals, mainly dimer acid, linoleic acid and isostearic acid, that go into paints, inks, epoxy hardeners and drilling fluids, selling to industrial customers in India and abroad.
Company snapshot
45thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Dividend payout of 176% — the company returns a meaningful share of profits to shareholders.
- ✗Net margin is very thin at 1.2% — little room for error if costs rise.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152 Cr | 148 Cr | 161 Cr | 165 Cr | 139 Cr | 114 Cr | 121 Cr | 131 Cr | 112 Cr | 100 Cr | 117 Cr | 176 Cr |
| Operating expenses (approx.) | 135 Cr | 128 Cr | 142 Cr | 143 Cr | 130 Cr | 106 Cr | 116 Cr | 126 Cr | 107 Cr | 96 Cr | 109 Cr | 158 Cr |
| EBITDA | 17 Cr | 20 Cr | 19 Cr | 22 Cr | 9 Cr | 8 Cr | 4 Cr | 5 Cr | 4 Cr | 4 Cr | 8 Cr | 18 Cr |
| OPM % | 11.1% | 13.3% | 11.7% | 13.2% | 6.3% | 6.9% | 3.7% | 4.0% | 3.8% | 4.2% | 6.9% | 10.1% |
| Other income | 0.46 Cr | 0.25 Cr | 0.28 Cr | 0.24 Cr | 0.38 Cr | 0.48 Cr | 0.24 Cr | 0.13 Cr | 0.37 Cr | 0.26 Cr | 0.54 Cr | 0.35 Cr |
| Interest | 1 Cr | 0.97 Cr | 0.62 Cr | 0.81 Cr | 1 Cr | 0.93 Cr | 0.91 Cr | 1 Cr | 0.61 Cr | 0.96 Cr | 1 Cr | 2 Cr |
| Depreciation | 2 Cr | 2 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Profit before tax | 14 Cr | 17 Cr | 16 Cr | 19 Cr | 5 Cr | 5 Cr | 1 Cr | 2 Cr | 1 Cr | -0.21 Cr | 5 Cr | 14 Cr |
| Tax % | 25.5% | 25.9% | 25.9% | 25.6% | 26.8% | 25.4% | 46.6% | 27.4% | 34.4% | 52.7% | 22.0% | 26.6% |
| Net profit | 10 Cr | 12 Cr | 12 Cr | 14 Cr | 4 Cr | 4 Cr | 0.59 Cr | 1 Cr | 0.77 Cr | -0.10 Cr | 4 Cr | 10 Cr |
| EPS (₹) | ₹7.90 | ₹9.47 | ₹9.03 | ₹10.64 | ₹3.08 | ₹2.70 | ₹0.46 | ₹0.90 | ₹0.59 | ₹-0.07 | ₹2.85 | ₹7.95 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 397 Cr | 643 Cr | 648 Cr | 621 Cr | 538 Cr | 460 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 328 Cr | 538 Cr | 576 Cr | 554 Cr | 495 Cr | 438 Cr | Sign in free for the trailing twelve months |
| EBITDA | 69 Cr | 105 Cr | 72 Cr | 67 Cr | 43 Cr | 22 Cr | Sign in free for the trailing twelve months |
| OPM % | 17.3% | 16.3% | 11.2% | 10.8% | 8.0% | 4.7% | Sign in free for the trailing twelve months |
| Other income | 0.28 Cr | 0.36 Cr | 0.68 Cr | 1 Cr | 1 Cr | 1 Cr | Sign in free for the trailing twelve months |
| Interest | 7 Cr | 7 Cr | 6 Cr | 4 Cr | 4 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Depreciation | 7 Cr | 7 Cr | 8 Cr | 9 Cr | 11 Cr | 11 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 56 Cr | 91 Cr | 59 Cr | 55 Cr | 30 Cr | 7 Cr | Sign in free for the trailing twelve months |
| Tax % | 23.5% | 25.6% | 25.8% | 25.8% | 26.6% | 24.3% | Sign in free for the trailing twelve months |
| Net profit | 42 Cr | 68 Cr | 44 Cr | 41 Cr | 22 Cr | 6 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹32.63 | ₹52.15 | ₹33.41 | ₹31.10 | ₹16.88 | ₹4.28 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 6.7% | 38.9% | 24.1% | 44.4% | 176.3% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 13 Cr | 13 Cr | 13 Cr | 13 Cr | 13 Cr | 13 Cr |
| Reserves | 156 Cr | 219 Cr | 246 Cr | 277 Cr | 289 Cr | 250 Cr |
| Borrowings | 48 Cr | 62 Cr | 50 Cr | 7 Cr | 63 Cr | 84 Cr |
| Other liabilities | 42 Cr | 30 Cr | 33 Cr | 37 Cr | 37 Cr | 44 Cr |
| Total liabilities | 259 Cr | 324 Cr | 342 Cr | 334 Cr | 402 Cr | 391 Cr |
| Fixed assets (net) | 126 Cr | 141 Cr | 156 Cr | 191 Cr | 201 Cr | 196 Cr |
| CWIP | 29 Cr | 42 Cr | 35 Cr | 6 Cr | 12 Cr | 18 Cr |
| Investments | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Loans & advances | 0.0017 Cr | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.0086 Cr |
| Inventories | 45 Cr | 70 Cr | 80 Cr | 70 Cr | 88 Cr | 92 Cr |
| Trade receivables | 47 Cr | 62 Cr | 63 Cr | 57 Cr | 86 Cr | 68 Cr |
| Cash & bank | 0.03 Cr | 0.0083 Cr | 0.0078 Cr | 0.0084 Cr | 0.0082 Cr | 0.01 Cr |
| Other assets | 11 Cr | 9 Cr | 9 Cr | 11 Cr | 15 Cr | 16 Cr |
| Total assets | 259 Cr | 324 Cr | 342 Cr | 334 Cr | 402 Cr | 391 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 39 Cr | 40 Cr | 50 Cr | 74 Cr | -17 Cr | 42 Cr |
| Cash from investing | -23 Cr | -34 Cr | -14 Cr | -18 Cr | -26 Cr | -14 Cr |
| Cash from financing | -17 Cr | -6 Cr | -35 Cr | -57 Cr | 42 Cr | -28 Cr |
| Net cash flow | -0.0048 Cr | -0.02 Cr | -0.0005 Cr | 0.0006 Cr | -0.0002 Cr | 0.0053 Cr |
| Free cash flow (OCF − Capex) | 16 Cr | 6 Cr | 35 Cr | 56 Cr | -43 Cr | 26 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 28.8% | 33.3% | 21.0% | 19.8% | 9.2% | 3.2% |
| ROE % | 25.2% | 29.3% | 16.8% | 14.0% | 7.3% | 2.1% |
| Debtor days | 43 | 35 | 35 | 33 | 58 | 54 |
| Inventory days | 59 | 54 | 58 | 56 | 77 | 90 |
| Days payable | 14 | 7 | 8 | 10 | 7 | 11 |
| Cash conversion cycle | 88 | 82 | 86 | 79 | 128 | 133 |
| OCF / EBITDA % | 57.4% | 38.6% | 68.6% | 111.2% | -39.2% | 192.4% |
| OCF / EBITDA % (3 years) | — | — | 52.7% | 67.4% | 58.9% | 75.6% |
| Debt / equity | 0.29 | 0.27 | 0.19 | 0.03 | 0.21 | 0.32 |
| Current ratio | 1.93 | 2.04 | 2.22 | 5.10 | 2.30 | 1.66 |
| Net debt / EBITDA | 0.70 | 0.59 | 0.69 | 0.11 | 1.47 | 3.88 |